27 sierpnia, 2020
Antibody Immunity than Vaccinees Despite Similar Levels of Circulating Immunoglobulins
Ebola Virus Illness Survivors Present Extra Environment friendly Antibody Immunity than Vaccinees Regardless of Comparable Ranges of Circulating Immunoglobulins
The final seven years have seen the best surge of Ebola virus illness (EVD) circumstances in equatorial Africa, together with the 2013-2016 epidemic in West Africa and the latest epidemics within the Democratic Republic of Congo (DRC). The vaccine scientific trials that befell in West Africa and the DRC, in addition to follow-up research in collaboration with EVD survivor communities, have for the primary time allowed researchers to check immune reminiscence induced by pure an infection and vaccination.
These comparisons could also be related to guage the putative effectiveness of vaccines and candidate medical countermeasures corresponding to convalescent plasma switch.
On this research, we in contrast the long-term performance of anti-EBOV glycoprotein (GP) antibodies from EVD survivors with that from volunteers who obtained the recombinant vesicular stomatitis virus vectored vaccine (rVSV-ZEBOV) throughout the Section I scientific trial in Hamburg.
Our research highlights necessary variations between EBOV vaccination and pure an infection and offers a framework for comparability with different vaccine candidates.
Recombinant Mouse IL-1 R2/IL-1 RII Protein |
|||
RP00726 | Abclonal | 10μg | EUR 136.5 |
|
anti-PKA R2 |
|||
YF-PA24454 | Abfrontier | 50 ul | EUR 400.8 |
Description: Mouse polyclonal to PKA R2 |
anti-PKA R2 |
|||
YF-PA13990 | Abfrontier | 50 ul | EUR 435.6 |
Description: Mouse polyclonal to PKA R2 |
Anti-TNF-R2 antibody |
|||
STJ96053 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: Rabbit polyclonal to TNF-R2. |
Anti-GABAB R2 antibody |
|||
STJ96379 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: Rabbit polyclonal to GABAB R2. |
Anti-TRAIL-R2 Antibody |
|||
A00410-1 | BosterBio | 200ug | EUR 565.2 |
Description: Goat Polyclonal TRAIL-R2 Antibody. Validated in IF, WB and tested in Human, Mouse. |
Anti-MonoMethylH3R2me1-(R2) antibody |
|||
STJ24010 | St John's Laboratory | 100 µl | EUR 471.6 |
Description: Histones are basic nuclear proteins that are responsible for the nucleosome structure of the chromosomal fiber in eukaryotes. Nucleosomes consist of approximately 146 bp of DNA wrapped around a histone octamer composed of pairs of each of the four core histones (H2A, H2B, H3, and H4). The chromatin fiber is further compacted through the interaction of a linker histone, H1, with the DNA between the nucleosomes to form higher order chromatin structures. This gene is intronless and encodes a replication-dependent histone that is a member of the histone H3 family. Transcripts from this gene lack polyA tails; instead, they contain a palindromic termination element. This gene is located separately from the other H3 genes that are in the histone gene cluster on chromosome 6p22-p21.3. |
TNF-R2 (human) |
|||
TN-004 | Kamiya Biomedical Company | 50 µg | EUR 738 |
Anti-PKA R2 (6A9) |
|||
YF-MA10721 | Abfrontier | 100 ug | EUR 435.6 |
Description: Mouse monoclonal to PKA R2 |
Anti-PKA R2 (3C7) |
|||
YF-MA14876 | Abfrontier | 100 ug | EUR 435.6 |
Description: Mouse monoclonal to PKA R2 |
Rat Anti-Mouse IL-12 p75 Monoclonal antibody, clone R2-9A5 |
|||
CABT-L4486-1mg | Creative Diagnostics | 1 mg | EUR 1076.4 |
Rat Anti-Mouse IL-12 p75 Monoclonal antibody, clone R2-9A5 |
|||
CABT-L4486-5mg | Creative Diagnostics | 5 mg | EUR 2886 |
IL 1 R2 Recombinant Protein His Tag Lyophilized |
|||
IIL1R2RHISLY100UG | Innovative research | each | EUR 721 |
|
|||
Description: IL 1 R2 Recombinant Protein His Tag Lyophilized |
Anti‐Human IL‐17A |
|||
E2790213 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
Anti-GABA(B) R2 Purified |
|||
11-551-C100 | ExBio | 0.1 mg | EUR 244.8 |
PE anti-human CD262 (DR5, TRAIL-R2) |
|||
E16FHP262-025 | EnoGene | 25 tests | EUR 476.67 |
Description: Available in various conjugation types. |
PE anti-human CD262 (DR5, TRAIL-R2) |
|||
E16FHP262-100 | EnoGene | 100 tests | EUR 1083.33 |
Description: Available in various conjugation types. |
APC anti-human CD262 (DR5, TRAIL-R2) |
|||
E16FHA262-025 | EnoGene | 25 tests | EUR 541.67 |
Description: Available in various conjugation types. |
APC anti-human CD262 (DR5, TRAIL-R2) |
|||
E16FHA262-100 | EnoGene | 100 tests | EUR 1278.33 |
Description: Available in various conjugation types. |
Purified anti-human CD262 (DR5, TRAIL-R2) |
|||
E16FHU262-100U | EnoGene | 100 μg | EUR 758.33 |
Description: Available in various conjugation types. |
human anti-human IL-5 mAb |
|||
E4A09D05 | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
human anti-human IL-2 mAb |
|||
E409C12-h100 | EnoGene | 100μL | EUR 395 |
Description: Available in various conjugation types. |
human anti-human IL-4 mAb |
|||
E409C13-h100 | EnoGene | 100μL | EUR 395 |
Description: Available in various conjugation types. |
human anti-human IL-5 mAb |
|||
E409C14-h100 | EnoGene | 100μL | EUR 395 |
Description: Available in various conjugation types. |
human anti-human IL-8 mAb |
|||
E409C16-h100 | EnoGene | 100μL | EUR 395 |
Description: Available in various conjugation types. |
human anti-human IL-1β mAb |
|||
E409C11-h100 | EnoGene | 100μL | EUR 395 |
Description: Available in various conjugation types. |
human anti-human IL-10 mAb |
|||
E409C17-h100 | EnoGene | 100μL | EUR 395 |
Description: Available in various conjugation types. |
Anti-PKA R2 Antibody [JE49-49] |
|||
ET7109-92 | HUABIO | 100ul | EUR 231 |
|
|||
Description: cAMP-dependent protein kinase type II-alpha regulatory subunit is an enzyme that in humans is encoded by the PRKAR2A gene. cAMP is a signaling molecule important for a variety of cellular functions. cAMP exerts its effects by activating the cAMP-dependent Protein Kinase, more commonly called Protein Kinase A (PKA), which transduces the signal through phosphorylation of different target proteins. The inactive holoenzyme of PKA is a tetramer composed of two regulatory and two catalytic subunits. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. Four different regulatory subunits and three catalytic subunits of PKA have been identified in humans. The protein encoded by this gene is one of the regulatory subunits. This subunit can be phosphorylated by the activated catalytic subunit. It may interact with various A-kinase anchoring proteins (AKAPs) and determine the subcellular localization of PKA. This subunit has been shown to regulate protein transport from endosomes to the Golgi apparatus and further to the endoplasmic reticulum (ER). |
Anti-Phospho-GABAB R2 (Ser783) Antibody |
|||
P03830 | BosterBio | 100ul | EUR 477.6 |
Description: Rabbit Polyclonal Phospho-GABAB R2 (Ser783) Antibody. Validated in IF, WB and tested in Mouse, Rat. |
Rabbit Polyclonal Anti-TNF-R2 Antibody |
|||
TA347563 | Origene Technologies GmbH | 100 µg | Ask for price |
Rabbit Polyclonal Anti-TNF-R2 Antibody |
|||
TA347564 | Origene Technologies GmbH | 100 µg | Ask for price |
VEGF-R2 (Human) ELISA Kit |
|||
EKA51976-5x96T | Biomatik Corporation | 5x96T | Ask for price |
VEGF-R2 (Human) ELISA Kit |
|||
EKA51976-96T | Biomatik Corporation | 96T | EUR 446.9 |
sTNF-R2 (Human) ELISA Kit |
|||
EKA52066-5x96T | Biomatik Corporation | 5x96T | Ask for price |
sTNF-R2 (Human) ELISA Kit |
|||
EKA52066-96T | Biomatik Corporation | 96T | EUR 446.9 |
TGFbeta-R2 (Human) ELISA Kit |
|||
EKA51981-5x96T | Biomatik Corporation | 5x96T | Ask for price |
TGFbeta-R2 (Human) ELISA Kit |
|||
EKA51981-96T | Biomatik Corporation | 96T | EUR 446.9 |
human anti-human IL-2 mAb (D1) |
|||
E4A09D03-A7C | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
human anti-human IL-2 mAb (F5) |
|||
E4A09D03-B1F | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
human anti-human IL-2 mAb (16) |
|||
E4A09D03-C3C | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
human anti-human IL-4 mAb (12) |
|||
E4A09D04-12 | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
human anti-human IL-4 mAb (52) |
|||
E4A09D04-52 | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
human anti-human IL-4 mAb (C1) |
|||
E4A09D04-C1 | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
human anti-human IL-6 mAb (A3) |
|||
E4A09D06-hA3 | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
human anti-human IL-8 mAb (A5) |
|||
E4A09D07-A5A | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
human anti-human IL-8 mAb (6G) |
|||
E4A09D07-B5G | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
human anti-human IL-8 mAb (AB) |
|||
E4A09D07-C8A | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
human anti-human IL-1β mAb (95) |
|||
E4A09D02-h9 | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
human anti-human IL-1β mAb (Ca) |
|||
E4A09D02-hA | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
human anti-human IL-1β mAb (Ge) |
|||
E4A09D02-hB | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
human anti-human IL-6 mAb (10C) |
|||
E4A09D06-h10C | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
human anti-human IL-6 mAb (2D2) |
|||
E4A09D06-hD2 | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
human anti-human IL-10 mAb (97) |
|||
E4A09D08-A9D | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
human anti-human IL-10 mAb (18) |
|||
E4A09D08-B2G | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
human anti-human IL-6 mAb (3H3H) |
|||
E4A09D06-h3H | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
human anti-human IL-6 mAb (1H4C) |
|||
E4A09D06-h4C | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
human anti-human IL-6 mAb (2H4Z) |
|||
E4A09D06-h4Z | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
human anti-human IL-6 mAb (4HC6) |
|||
E4A09D06-hC6 | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
human anti-human IL-12 mAb (AB1) |
|||
E4A09D20-AB1 | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
human anti-human IL-12 mAb (AB2) |
|||
E4A09D20-AB2 | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
Rabbit Polyclonal Anti-GABA (B) R2 |
|||
TA328675 | Origene Technologies GmbH | 200 µl | Ask for price |
human anti-human IL-17A mAb (AB3) |
|||
E4A09D09-AB3 | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
human anti-human IL-17A mAb (AB4) |
|||
E4A09D09-AB4 | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
human anti-human IL-17A mAb (AB6) |
|||
E4A09D09-AB6 | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
TRAIL-R2, Human Recombinant Protein |
|||
TR-005 | Kamiya Biomedical Company | 50 µg | EUR 703 |
Rabbit anti-Histone H3 (MonoMethyl R2) Antibody |
|||
YLD3941-100ul | Shanghai YL Biotech | 100 ul | EUR 320 |
|
|||
Description: Rabbit polyclonal antibody to Histone H3 (MonoMethyl R2) |
Rabbit anti-Histone H3 (MonoMethyl R2) Antibody |
|||
YLD3941-50ul | Shanghai YL Biotech | 50 ul | EUR 200 |
|
|||
Description: Rabbit polyclonal antibody to Histone H3 (MonoMethyl R2) |
Rabbit anti-Histone H3 (MonoMethyl R2) Antibody |
|||
DL95700A-100ul | DL Develop | 100 ul | EUR 370 |
|
|||
Description: HIST1H3A; H3FA; HIST1H3B; H3FL; HIST1H3C; H3FC; HIST1H3D; H3FB; HIST1H3E; H3FD; HIST1H3F; H3FI; HIST1H3G; H3FH; HIST1H3H; H3FK; HIST1H3I; H3FF; HIST1H3J; H3FJ; Histone H3.1; Histone H3/a; Histone H3/b; Histone H3/c; Histone H3/d; Histone H3/f; Histone H3/h; Histone H3/i; Histone H3/j; Histone H3/k; Histone H3/l; HIST2H3A; HIST2H3C; H3F2; H3FM; HIST2H3D; Histone H3.2; Histone H3/m; Histone H3/o; H3F3A; H3.3A; H3F3; PP781; H3F3B; H3.3B; Histone H3.3 |
Rabbit anti-Histone H3 (MonoMethyl R2) Antibody |
|||
DL95700A-50ul | DL Develop | 50 ul | EUR 259 |
|
|||
Description: HIST1H3A; H3FA; HIST1H3B; H3FL; HIST1H3C; H3FC; HIST1H3D; H3FB; HIST1H3E; H3FD; HIST1H3F; H3FI; HIST1H3G; H3FH; HIST1H3H; H3FK; HIST1H3I; H3FF; HIST1H3J; H3FJ; Histone H3.1; Histone H3/a; Histone H3/b; Histone H3/c; Histone H3/d; Histone H3/f; Histone H3/h; Histone H3/i; Histone H3/j; Histone H3/k; Histone H3/l; HIST2H3A; HIST2H3C; H3F2; H3FM; HIST2H3D; Histone H3.2; Histone H3/m; Histone H3/o; H3F3A; H3.3A; H3F3; PP781; H3F3B; H3.3B; Histone H3.3 |
Anti-GABAB Receptor (Ser783), R2-Subunit antibody |
|||
STJ120094 | St John's Laboratory | 100 µl | EUR 631.2 |
human anti-human CD25/IL-2RA mAb (AB2) |
|||
E4A09C17-AB2 | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
human anti-human CD25/IL-2RA mAb (AB3) |
|||
E4A09C17-AB3 | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
human anti-human CD25/IL-2RA mAb (ABD) |
|||
E4A09C17-ABD | EnoGene | 50ug | EUR 255 |
Description: Available in various conjugation types. |
Human VEGF R2/KDR ELISA Kit |
|||
E28L0577 | EnoGene | 96T | EUR 666.67 |
mAb rat anti-mouse/human IL-5 |
|||
CT694 | U-CyTech | 0.5 mg | EUR 312 |
Anti-IL-4Rα (Dupilumab), Human IgG4 Antibody |
|||
A2148-100 | Biovision | 100 µg | EUR 612 |
IFN -gamma R2 ELISA KIT|Human |
|||
EF010951 | Lifescience Market | 96 Tests | EUR 826.8 |
Anti-IL-1β (Canakinumab), Human IgG1 Antibody |
|||
A2144-100 | Biovision | 100 µg | EUR 564 |
Anti-IL-23α (Guselkumab), Human IgG1 Antibody |
|||
A2147-100 | Biovision | 100 µg | EUR 612 |
Anti-IL-12β (Ustekinumab), Human IgG1 Antibody |
|||
A2137-100 | Biovision | 100 µg | EUR 612 |
Anti-IL-17α (Secukinumab), Human IgG1 Antibody |
|||
A2154-100 | Biovision | 100 µg | EUR 612 |
Anti-IL-17Rα (Brodalumab), Human IgG2 Antibody |
|||
A2155-100 | Biovision | 100 µg | EUR 612 |
PE anti-mouse CD262 (DR5, TRAIL-R2) |
|||
E16FMP262-050U | EnoGene | 50 μg | EUR 476.67 |
Description: Available in various conjugation types. |
PE anti-mouse CD262 (DR5, TRAIL-R2) |
|||
E16FMP262-200U | EnoGene | 200 μg | EUR 1451.67 |
Description: Available in various conjugation types. |
Mechanism of Antibodies Purification by Protein A
Protein A, a serious cell wall part of Staphylococcus aureus, is likely one of the first immunoglobulin-binding proteins that’s found about 80 years in the past. Nonetheless, an excessive amount of improvement in each purification strategies and software of antibodies in therapy have been executed.
There are numerous publications primarily based on the untargeted (dimension exclusion, ion alternate and hydrophobic interactions) and focused (affinity) strategies by scientists in tutorial/trade teams. On this evaluate, now we have centered on the research of each native and engineered Protein A to grasp its mechanism within the purification of antibodies.
What area of Protein A dose work together with antibody? The place are contact areas? What’s the non-covalent interplay mechanism of Protein A and antibody? Does alkaline situation, within the washing step, affect on antibody construction and exercise? Then again, the immobilization of Protein A on numerous sorbents corresponding to agarose, silica, polysaccharide, polymers, and magnetic nanoparticles have investigated.
Additionally, the appliance of Protein A as biosensor for detection of the antibody is mentioned. We’ve got tried to seek out fascinating and stimulating solutions to all these questions.
Selective elimination of human pluripotent stem cells by Anti-Dsg2 antibody-doxorubicin conjugates
The self-renewal properties of human pluripotent stem cells (hPSCs) contribute to their efficacy in tissue regeneration purposes but improve the probability of teratoma formation, thereby limiting their scientific utility. To deal with this difficulty, we developed a device to particularly goal and neutralize undifferentiated hPSCs, thereby minimizing tumorigenicity danger with out negatively affecting regenerated and somatic tissues.
Particularly, we conjugated a monoclonal antibody (K6-1) beforehand generated in our laboratory in opposition to desmoglein 2 (Dsg2), which is extremely differentially expressed in undifferentiated hPSCs versus somatic tissues, to the chemotherapeutic agent doxorubicin (DOX).
The K6-1-DOX conjugates had been selectively focused and included into Dsg2-positive hPSCs, resulting in pH-dependent endosomal launch and nuclear localization of DOX with subsequent cytotoxicity by way of an apoptotic caspase cascade. Conversely, Dsg2-negative fibroblasts confirmed minimal conjugate uptake or cytotoxicity, suggesting that K6-1-DOX therapy would yield few unintended effects owing to off-target results.
Selective elimination of undifferentiated stem cells was additionally supported by in vivo research utilizing a mouse xenograft mannequin, whereby hIgG-DOX- however not K6-1-DOX-pretreated-hPSC injection led to teratoma improvement. Collectively, these outcomes validated the flexibility of the Dsg2-targeted antibody-anticancer drug conjugate to facilitate the security of stem cell therapies.
Antibody Conjugation of Nanoparticles as Therapeutics for Breast Most cancers Remedy
Breast most cancers is the most typical invasive tumor in girls and the second main reason behind cancer-related loss of life. Nanomedicine raises excessive expectations for hundreds of thousands of sufferers as it might probably present higher, extra environment friendly, and reasonably priced healthcare, and it has the potential to develop novel therapeutics for the therapy of strong tumors.
On this regard, focused therapies will be encapsulated into nanocarriers, and these nanovehicles are guided to the tumors via conjugation with antibodies-the so-called antibody-conjugated nanoparticles (ACNPs). ACNPs can protect the chemical construction of medicine, ship them in a managed method, and cut back toxicity.
As sure breast most cancers subtypes and indications have restricted therapeutic choices, this discipline offers hope for the long run therapy of sufferers with troublesome to deal with breast cancers. On this evaluate, we talk about the appliance of ACNPs for the therapy of this illness. Given the truth that ACNPs have proven scientific exercise on this scientific setting, particular emphasis on the function of the nanovehicles and their translation to the clinic is positioned on the revision.
Recombinant Human Junctional Adhesion Molecule B/JAM-B/CD322 (C-Fc) |
|||
CC52-500ug | Novoprotein | 500ug | EUR 1935.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4 . |
Recombinant Human Junctional Adhesion Molecule B/JAM-B/CD322 (C-Fc) |
|||
CC52-50ug | Novoprotein | 50ug | EUR 363.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4 . |
Recombinant Human Junctional Adhesion Molecule B/JAM-B/CD322 (C-Fc) |
|||
AP75554 | SAB | 1mg | EUR 3209 |
|
Recombinant Human Junctional Adhesion Molecule B/JAM-B/CD322 (C-6His) |
|||
C359-10ug | Novoprotein | 10ug | EUR 145.2 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.2. |
Recombinant Human Junctional Adhesion Molecule B/JAM-B/CD322 (C-6His) |
|||
C359-1mg | Novoprotein | 1mg | EUR 2739.6 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.2. |
Recombinant Human Junctional Adhesion Molecule B/JAM-B/CD322 (C-6His) |
|||
C359-500ug | Novoprotein | 500ug | EUR 1935.6 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.2. |
Recombinant Human Junctional Adhesion Molecule B/JAM-B/CD322 (C-6His) |
|||
C359-50ug | Novoprotein | 50ug | EUR 315.6 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.2. |
Recombinant Human Junctional Adhesion Molecule B/JAM-B/CD322 (C-6His) |
|||
AP75079 | SAB | 1mg | EUR 3209 |
|
Human Junctional Adhesion Molecule 2/JAM-B Antibody (Biotin Conjugate) |
|||
33424-05121 | AssayPro | 150 ug | EUR 442.8 |
Human Junctional Adhesion Molecule 2/JAM-B AssayLite Antibody (FITC Conjugate) |
|||
33424-05141 | AssayPro | 150 ug | EUR 513.6 |
Human Junctional Adhesion Molecule 2/JAM-B AssayLite Antibody (RPE Conjugate) |
|||
33424-05151 | AssayPro | 150 ug | EUR 513.6 |
Human Junctional Adhesion Molecule 2/JAM-B AssayLite Antibody (APC Conjugate) |
|||
33424-05161 | AssayPro | 150 ug | EUR 513.6 |
Human Junctional adhesion molecule B, JAM2 ELISA KIT |
|||
ELI-12652h | Lifescience Market | 96 Tests | EUR 988.8 |
Human Junctional adhesion molecule B(JAM2) Elisa Kit |
|||
EK712797 | AFG Bioscience LLC | 96 Wells | EUR 0.29 |
JAM-A Antibody / Junctional adhesion molecule 1 |
|||
RQ5813 | NSJ Bioreagents | 100 ug | EUR 356.15 |
Description: Junctional adhesion molecule A is a protein that in humans is encoded by the F11R gene. Tight junctions represent one mode of cell-to-cell adhesion in epithelial or endothelial cell sheets, forming continuous seals around cells and serving as a physical barrier to prevent solutes and water from passing freely through the paracellular space. The protein encoded by this immunoglobulin superfamily gene member is an important regulator of tight junction assembly in epithelia. In addition, the encoded protein can act as (1) a receptor for reovirus, (2) a ligand for the integrin LFA1, involved in leukocyte transmigration, and (3) a platelet receptor. Multiple 5' alternatively spliced variants, encoding the same protein, have been identified but their biological validity has not been established. |
JAM-A Antibody / Junctional adhesion molecule 1 |
|||
R20292-0.1ML | NSJ Bioreagents | 100ul | EUR 347.65 |
Description: This recombinant JAM-A antibody reacts to human JAM1 (Junctional adhesion molecule 1). |
Human Junctional Adhesion Molecule 2/JAM-B AssayLite Antibody (PerCP Conjugate) |
|||
33424-05171 | AssayPro | 150 ug | EUR 565.2 |
Rabbit Polyclonal antibody to JAM-B (junctional adhesion molecule 2) |
|||
TA308335 | Origene Technologies GmbH | 100 µl | Ask for price |
Human Junctional Adhesion Molecule B, JAM2 GENLISA ELISA |
|||
KBH5529 | Krishgen | 1 x 96 wells | EUR 286 |
Junctional adhesion molecule B Antibody |
|||
20-abx109951 | Abbexa |
|
|
|
Recombinant Human Junctional adhesion molecule B(JAM2),partial |
|||
AP72631 | SAB | 1mg | EUR 2303 |
|
Recombinant Human Junctional adhesion molecule B(JAM2),partial |
|||
AP70459 | SAB | 1mg | EUR 1978 |
|
Human Junctional Adhesion Molecule B ELISA Kit |
|||
IHUJAMBKT | Innovative research | each | EUR 702 |
|
|||
Description: Human Junctional Adhesion Molecule B ELISA Kit |
Mouse Junctional adhesion molecule B, Jam2 ELISA KIT |
|||
ELI-28041m | Lifescience Market | 96 Tests | EUR 1038 |
Junctional adhesion molecule B Antibody (HRP) |
|||
20-abx108442 | Abbexa |
|
|
|
Junctional adhesion molecule B Antibody (FITC) |
|||
20-abx107021 | Abbexa |
|
|
|
Junctional adhesion molecule B Antibody (Biotin) |
|||
20-abx105603 | Abbexa |
|
|
|
Recombinant Human Junctional Adhesion Molecule A/JAM-A/CD321 (C-6His) |
|||
C468-10ug | Novoprotein | 10ug | EUR 187.2 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM TrisHCl, 50mM NaCl, 100mM Glycine, pH 7.5. |
Recombinant Human Junctional Adhesion Molecule A/JAM-A/CD321 (C-6His) |
|||
C468-1mg | Novoprotein | 1mg | EUR 2739.6 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM TrisHCl, 50mM NaCl, 100mM Glycine, pH 7.5. |
Recombinant Human Junctional Adhesion Molecule A/JAM-A/CD321 (C-6His) |
|||
C468-500ug | Novoprotein | 500ug | EUR 1935.6 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM TrisHCl, 50mM NaCl, 100mM Glycine, pH 7.5. |
Recombinant Human Junctional Adhesion Molecule A/JAM-A/CD321 (C-6His) |
|||
C468-50ug | Novoprotein | 50ug | EUR 442.8 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM TrisHCl, 50mM NaCl, 100mM Glycine, pH 7.5. |
Recombinant Human Junctional Adhesion Molecule A/JAM-A/CD321 (C-6His) |
|||
AP75170 | SAB | 1mg | EUR 3209 |
|
Human Junctional Adhesion Molecule 1 (JAM1) Protein |
|||
20-abx168264 | Abbexa |
|
|
|
Human Junctional Adhesion Molecule 3 (JAM3) Protein |
|||
20-abx651016 | Abbexa |
|
|
|
Human Junctional Adhesion Molecule 2 (JAM2) Protein |
|||
20-abx166507 | Abbexa |
|
|
|
Junctional Adhesion Molecule 2 (JAM2) Antibody |
|||
20-abx135898 | Abbexa |
|
|
|
Junctional Adhesion Molecule 1 (JAM1) Antibody |
|||
20-abx270085 | Abbexa |
|
|
|
Junctional Adhesion Molecule 2 (JAM2) Antibody |
|||
abx234435-100ug | Abbexa | 100 ug | EUR 610.8 |
|
Junctional Adhesion Molecule 2 (JAM2) Antibody |
|||
20-abx109950 | Abbexa |
|
|
|
Junctional Adhesion Molecule 1 (JAM1) Antibody |
|||
20-abx173215 | Abbexa |
|
|
|
Junctional Adhesion Molecule 2 (JAM2) Antibody |
|||
20-abx173216 | Abbexa |
|
|
|
Junctional Adhesion Molecule 3 (JAM3) Antibody |
|||
20-abx173217 | Abbexa |
|
|
|
Junctional Adhesion Molecule 3 (JAM3) Antibody |
|||
20-abx177235 | Abbexa |
|
|
|
Junctional Adhesion Molecule 3 (JAM3) Antibody |
|||
20-abx216346 | Abbexa |
|
|
|
Junctional Adhesion Molecule 2 (JAM2) Antibody |
|||
20-abx148748 | Abbexa |
|
|
|
Junctional Adhesion Molecule 2 (JAM2) Antibody |
|||
20-abx327593 | Abbexa |
|
|
|
Junctional Adhesion Molecule 2 (JAM2) Antibody |
|||
20-abx113297 | Abbexa |
|
|
|
Junctional Adhesion Molecule 2 (JAM2) Antibody |
|||
abx027880-400ul | Abbexa | 400 ul | EUR 627.6 |
|
Junctional Adhesion Molecule 2 (JAM2) Antibody |
|||
abx027880-80l | Abbexa | 80 µl | EUR 343.2 |
|
Junctional Adhesion Molecule 2 (JAM2) Antibody |
|||
20-abx128023 | Abbexa |
|
|
|
Junctional Adhesion Molecule 1 (JAM1) Antibody |
|||
20-abx128588 | Abbexa |
|
|
|
Junctional Adhesion Molecule 3 (JAM3) Antibody |
|||
20-abx129330 | Abbexa |
|
|
|
Junctional Adhesion Molecule 3 (JAM3) Antibody |
|||
20-abx338850 | Abbexa |
|
|
|
Junctional Adhesion Molecule 2 (JAM2) Antibody |
|||
abx430155-200ul | Abbexa | 200 ul | EUR 460.8 |
|
Junctional Adhesion Molecule 2 (JAM2) Antibody |
|||
abx430245-200ul | Abbexa | 200 ul | EUR 343.2 |
|
Junctional Adhesion Molecule 2 (JAM2) Antibody |
|||
abx145733-100ug | Abbexa | 100 ug | EUR 469.2 |
|
Human Junctional Adhesion Molecule 1 (JAM1) CLIA Kit |
|||
20-abx493071 | Abbexa |
|
|
|
Human Junctional Adhesion Molecule 2 (JAM2) CLIA Kit |
|||
20-abx493072 | Abbexa |
|
|
|
Human Junctional Adhesion Molecule 3 (JAM3) CLIA Kit |
|||
20-abx495949 | Abbexa |
|
|
|
Human Junctional Adhesion Molecule 1 (JAM1) ELISA Kit |
|||
20-abx152073 | Abbexa |
|
|
|
Human Junctional Adhesion Molecule 2 (JAM2) ELISA Kit |
|||
20-abx152074 | Abbexa |
|
|
|
Human Junctional Adhesion Molecule 3 (JAM3) ELISA Kit |
|||
20-abx152075 | Abbexa |
|
|
|
Human Junctional Adhesion Molecule 1 (JAM1)ELISA Kit |
|||
201-12-2769 | SunredBio | 96 tests | EUR 528 |
|
|||
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
Human Junctional Adhesion Molecule 3 (JAM3)ELISA Kit |
|||
201-12-2770 | SunredBio | 96 tests | EUR 528 |
|
|||
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
Human Junctional Adhesion Molecule 1 (JAM1) ELISA Kit |
|||
DLR-JAM1-Hu-48T | DL Develop | 48T | EUR 597.6 |
|
|||
Description: A sandwich quantitative ELISA assay kit for detection of Human Junctional Adhesion Molecule 1 (JAM1) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Human Junctional Adhesion Molecule 1 (JAM1) ELISA Kit |
|||
DLR-JAM1-Hu-96T | DL Develop | 96T | EUR 776.4 |
|
|||
Description: A sandwich quantitative ELISA assay kit for detection of Human Junctional Adhesion Molecule 1 (JAM1) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Human Junctional Adhesion Molecule 2 (JAM2) ELISA Kit |
|||
DLR-JAM2-Hu-48T | DL Develop | 48T | EUR 574.8 |
|
|||
Description: A sandwich quantitative ELISA assay kit for detection of Human Junctional Adhesion Molecule 2 (JAM2) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Human Junctional Adhesion Molecule 2 (JAM2) ELISA Kit |
|||
DLR-JAM2-Hu-96T | DL Develop | 96T | EUR 745.2 |
|
|||
Description: A sandwich quantitative ELISA assay kit for detection of Human Junctional Adhesion Molecule 2 (JAM2) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Human Junctional Adhesion Molecule 3 (JAM3) ELISA Kit |
|||
DLR-JAM3-Hu-48T | DL Develop | 48T | EUR 664.8 |
|
|||
Description: A sandwich quantitative ELISA assay kit for detection of Human Junctional Adhesion Molecule 3 (JAM3) in samples from serum, plasma or other biological fluids. |
Human Junctional Adhesion Molecule 3 (JAM3) ELISA Kit |
|||
DLR-JAM3-Hu-96T | DL Develop | 96T | EUR 870 |
|
|||
Description: A sandwich quantitative ELISA assay kit for detection of Human Junctional Adhesion Molecule 3 (JAM3) in samples from serum, plasma or other biological fluids. |
Human Junctional adhesion molecule C, JAM3 ELISA KIT |
|||
ELI-08043h | Lifescience Market | 96 Tests | EUR 988.8 |
Human Junctional Adhesion Molecule 3 (JAM3) ELISA Kit |
|||
SEL637Hu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | EUR 6227.58 |
|
|||
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Junctional Adhesion Molecule 3 (JAM3) in serum, plasma and other biological fluids. |
Human Junctional Adhesion Molecule 3 (JAM3) ELISA Kit |
|||
SEL637Hu-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | EUR 618.04 |
|
|||
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Junctional Adhesion Molecule 3 (JAM3) in serum, plasma and other biological fluids. |
Human Junctional Adhesion Molecule 3 (JAM3) ELISA Kit |
|||
SEL637Hu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | EUR 831.48 |
|
|||
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Junctional Adhesion Molecule 3 (JAM3) in serum, plasma and other biological fluids. |
Human Junctional Adhesion Molecule 3 (JAM3) ELISA Kit |
|||
SEL637Hu-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | EUR 3381.66 |
|
|||
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Junctional Adhesion Molecule 3 (JAM3) in serum, plasma and other biological fluids. |
Human Junctional Adhesion Molecule 3 (JAM3) ELISA Kit |
|||
4-SEL637Hu | Cloud-Clone |
|
|
|
|||
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Junctional Adhesion Molecule 3 (JAM3) in samples from Serum, plasma and other biological fluids. with no significant corss-reactivity with analogues from other species. |
Human Junctional Adhesion Molecule 1 (JAM1) ELISA Kit |
|||
SEB782Hu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | EUR 5402.92 |
|
|||
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Junctional Adhesion Molecule 1 (JAM1) in serum, plasma, tissue homogenates and other biological fluids. |
Human Junctional Adhesion Molecule 1 (JAM1) ELISA Kit |
|||
SEB782Hu-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | EUR 550.13 |
|
|||
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Junctional Adhesion Molecule 1 (JAM1) in serum, plasma, tissue homogenates and other biological fluids. |
Human Junctional Adhesion Molecule 1 (JAM1) ELISA Kit |
|||
SEB782Hu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | EUR 734.46 |
|
|||
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Junctional Adhesion Molecule 1 (JAM1) in serum, plasma, tissue homogenates and other biological fluids. |
Human Junctional Adhesion Molecule 1 (JAM1) ELISA Kit |
|||
SEB782Hu-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | EUR 2945.08 |
|
|||
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Junctional Adhesion Molecule 1 (JAM1) in serum, plasma, tissue homogenates and other biological fluids. |
Human Junctional Adhesion Molecule 1 (JAM1) ELISA Kit |
|||
4-SEB782Hu | Cloud-Clone |
|
|
|
|||
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Junctional Adhesion Molecule 1 (JAM1) in samples from Serum, plasma, tissue homogenates and other biological fluids with no significant corss-reactivity with analogues from other species. |
Human Junctional Adhesion Molecule 2 (JAM2) ELISA Kit |
|||
SEB783Hu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | EUR 5128.02 |
|
|||
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Junctional Adhesion Molecule 2 (JAM2) in serum, plasma, tissue homogenates and other biological fluids. |
Human Junctional Adhesion Molecule 2 (JAM2) ELISA Kit |
|||
SEB783Hu-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | EUR 527.48 |
|
|||
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Junctional Adhesion Molecule 2 (JAM2) in serum, plasma, tissue homogenates and other biological fluids. |
Human Junctional Adhesion Molecule 2 (JAM2) ELISA Kit |
|||
SEB783Hu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | EUR 702.12 |
|
|||
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Junctional Adhesion Molecule 2 (JAM2) in serum, plasma, tissue homogenates and other biological fluids. |